Investigación / Grupos de investigación

Grupo  1

Fisiopatología e Investigación Clínica de las Enfermedades de Base Inmunológica e Inflamatoria Crónicas

Publicaciones (261)

  • Valero-Martínez, C; Pardines-Ortiz, M; Montes, N; Ortiz, AM; García-Vicuña, R; González-Alvaro, I; Triguero-Martínez, A.

    Galectin-1 levels do not predict outcomes in undifferentiated arthritis: a two-year prospective observational study

    Frontiers in Immunology. 2026; 17: [doi:10.3389/fimmu.2026.1757168]

  • Miranda-Bautista J; Martínez-Lozano H; Di Natale M; Mejía González MA; Marín-Jiménez I; Sánchez-Mateos P; Peligros Gómez MI; Rincón D; Bañares R; Menchén L.

    The Prognostic Impact of Enteropathy and Liver Disease in Common Variable Immunodeficiency: A Retrospective Cohort Study.

    Clinical and Translational Gastroenterology. 2026; 17(2): [doi:10.14309/ctg.0000000000000952]

  • Arnaiz-Villena, A; Lledo, T; Vaquero-Yuste, C; Juarez, I; Martin-Villa, JM.

    Enterocyte Autoantibodies (GECAs) and HLA: Their Relationship with HIV Infection Pathogenesis

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026; 27(3): [doi:10.3390/ijms27031254]

  • Tato-Moreno, P; Olleros, CL; Martín, HB; Guerrero, MB; Mensa-Vilaro, A; Durán-García, ME; Sánchez-Mateos, P; García-Martínez, E.

    Exploring targeted therapy in retinal vasculopathy with cerebral leukoencephalopathy: a case report and review of literature

    Frontiers in Immunology. 2026; 16: 1707532-1707532 [doi:10.3389/fimmu.2025.1707532]

  • Vaquero-Yuste, C; Juarez, I; Molina-Alejandre, M; Gutiérrez-Calvo, A; Lopez-García, A; Lasa, I; Gomez, R; Arnaiz-Villena, A; Martín-Villa, JM.

    Hampered CD8+ILT2+T cell activation by HLA-G suggests a new immune checkpoint in gastric adenocarcinoma

    Gastric Cancer. 2025; 29(1): 83-96 Nº de citas: 1 [doi:10.1007/s10120-025-01689-5]

  • García-Martínez, E; Nieto-Valle, A; Barrio-Alonso, C; López-Navarro, B; Avilés-Izquierdo, JA; Parra-Blanco, V; Gutiérrez-Seijo, A; Sánchez-Mateos, P; Samaniego, R.

    Adverse prognosis of GM-CSF expression in human cutaneous melanoma

    NEOPLASIA. 2025; 70: [doi:10.1016/j.neo.2025.101240]

  • Arnaiz-Villena, A; Juarez, I; Vaquero-Yuste, C; Lledo, T; Martín-Villa, JM; Suarez-Trujillo, F.

    Two different complement Factor B (Bf) alleles of the orangutan major histocompatibility complex (MHC) are also conserved in chimpanzee and humans showing importance in primate immunity

    MOLECULAR BIOLOGY REPORTS. 2025; 52(1): [doi:10.1007/s11033-024-10086-7]

  • Portela-Sánchez, S; Catalina, I; Muñoz, SL; Ros, AL; Sánchez-Soblechero, A; Vendrel, ES; Sánchez-Mateos, P; Muñoz-Blancoa, JL.

    Immune-mediated necrotizing myopathy: experience in a neuromuscular unit

    NEUROLOGIA. 2025; 40(8): 729-738 [doi:10.1016/j.nrl.2023.03.005]

  • Alba-Cano, T; Alonso, R; Balastegui-Martín, H; Bravo-Gallego, LY; Sánchez-Mateos, P; Martín-López, M; Gil-Herrera, J.

    Impact of CMV latency on T-cell responses to COVID-19 vaccination among predominantly antibody-deficient patients

    Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1659259]

  • Zhang, FH; Al-Amin, MY; Utturkar, S; Jiang, RA; Cresswell, G; Alfar, R; Ophaug-Johansen, I; Bachman, G; Srinivasarao, M; Finnell, R; Puig-Kröger, A; Ratliff, T; Low, PS.

    Folate receptor ß performs an immune checkpoint function in activated macrophages

    Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1638907]

  • Martínez-López, S; Juanola, O; Gómez-Hurtado, I; Angel-Gomis, E; Boix, P; Fernández-Iglesias, A; Gallardo-Cruz, A; Cubero, FJ; Gracia-Sancho, J; Puig-Kröger, A; Caparrós, E; Francés, R.

    LSECtin attenuates hepatic Th17 expansion in a murine model of cirrhosis and signals through the LAG-3 receptor

    Jhep Reports. 2025; 7(9): [doi:10.1016/j.jhepr.2025.101482]

  • García-Martínez, E; Schiaffino, MT; Di Natale, M; Luna, MDD; Alvarez, DAV; González, MAM.

    From syndromic clues to diagnosis: understanding CARD11-driven disorders

    Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1626065]

  • Sánchez, MS; Garcia-Martínez, E; Martín, HB; Durán-García, ME; Olleros, CL.

    Use of anakinra in cryopyrin-associated periodic syndromes: case report and review of literature

    Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1591234]

  • Rios, I; Herrero, C; Torres-Torresano, M; López-Navarro, B; Schiaffino, MT; Crespo, FD; Nieto-Valle, A; Samaniego, R; Sierra-Palomares, Y; Oliver, E; Revuelta-Salgado, F; García-Luján, R; Sánchez-Mateos, P; Delgado, R; Puig-Kröger, A; Corbi, AL.

    Reprogramming of GM-CSF-dependent alveolar macrophages through GSK3 activity modulation

    eLife. 2025; 14: [doi:10.7554/eLife.102659]

  • Barrio-Alonso, C; Nieto-Valle, A; Barandalla-Revilla, L; Avilés-Izquierdo, JA; Parra-Blanco, V; Sánchez-Mateos, P; Samaniego, R.

    Translating genetics into tissue: inflammatory cytokine-producing TAMs and PD-L1 tumor expression as poor prognosis factors in cutaneous melanoma

    Frontiers in Immunology. 2025; 16: [doi:10.3389/fimmu.2025.1587545]

  • Garate-Soraluze, E; Serrano-Mendioroz, I; Fernández-Rubio, L; De Andrea, CE; Barrio-Alonso, C; Herrero, CD; Teijeira, A; Luri-Rey, C; Claus, C; Tanos, T; Klein, C; Umana, P; Rullan, A; Simón, JA; Collantes, M; Sánchez-Mateos, P; Melero, I; Rodriguez-Ruiz, ME.

    4-1BB agonist targeted to fibroblast activation protein a synergizes with radiotherapy to treat murine breast tumor models

    Journal for ImmunoTherapy of Cancer. 2025; 13(1): Nº de citas: 2 [doi:10.1136/jitc-2024-009852]

  • González-Novo R; Armesto M; González-Murillo Á; Dreger M; Hurlstone AFL; Benito A; Samaniego R; Ramírez M; Redondo-Muñoz J.

    Dual effect of targeting LSD1 on the invasiveness and the mechanical response of acute lymphoblastic leukemia cells.

    BIOMEDICINE & PHARMACOTHERAPY. 2025; 183: 117830-117830 [doi:10.1016/j.biopha.2025.117830]

  • Molina-Alejandre, M; Juárez, I; Vaquero-Yuste, C; Gorroño-Echebarría, M; Molanes-López, EM; Fernandez-Cruz, E; Rodriguez-Sainz, C; Arnaiz-Villena, A; Martin-Villa, JM.

    HLA-G Polymorphisms of The 3'-UTR Region Are Involved in Susceptibility to Non-Infectious Uveitis

    OCULAR IMMUNOLOGY AND INFLAMMATION. 2025; 33(5): 806-811 [doi:10.1080/09273948.2025.2455969]